Adlai Nortye

Developer of immune oncolytic therapies for treating cancer

placeHangzhou, Zhejiang, China calendar_todayFounded 2014 groups27 employees language adlainortye.com

Registered entities

Social engagement

Social engagement: 1.7K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

17 investors on record; lead investors include SDIC, Tigermed, Matrix Partners China, Yuan Ming Capital.

Investor typeCountShare
Venture capital741%
Private equity318%
Other / undisclosed741%

Recent activity

1 Jul 2026
Leadership hire
Director of Investor Relations
Coming soon